Wouter Lokerse
Wouter Lokerse is a Junior Patent Associate in the Swedish Chemistry and Life Science team. In 2017, he obtained his PhD in Pharmaceutical Sciences/Oncology at Erasmus University, Rotterdam. Before joining AWA, Wouter worked as a Principal Scientist in the pharmaceutical industry.
Wouter is an accomplished scientist specialising in cell- and molecular biology, pharmaceutical science, biotechnology, and vaccines and has worked in various kinds of organisations, ranging from academia to large pharmaceutical companies.
Contact information
Phone:
+46 31 63 02 25Email:
wouter.lokerse@awa.comVisiting address:
Extended profile
He is well-equipped to deal with many scientific topics, such as pre-clinical characterisation and testing of candidate therapeutics (small molecules, biomolecules, and cells), drug delivery technology, pharmacology, and target product profile strategy. Furthermore, he is knowledgeable about various therapeutic indications, such as oncology, cardiovascular diseases, and infectious diseases.
In his previous roles, Wouter led many initiatives regarding competitive intelligence, external technology due diligence, intellectual property assessment and partnering.
These combined qualities ensure that Wouter can deal with various technologies presented by clients, guaranteeing high-quality service with a holistic invention-to-product perspective. At AWA, he supports his clients by drafting and prosecuting patent applications, novelty searches, patentability analyses, patent oppositions, and FTO analyses.
Practices
- IP due diligence
- IP Strategy
- Oppositions
- Patents
- Prosecution
Industries
- Advanced Therapeutic Medical Products (ATMP)
- Biochemistry/Molecular Biology
- Biotechnology
- Chemistry
- Life sciences
- Materials technology & nanotech
- Medtech
- Pharma
- Polymer Engineering
Languages
- Dutch
- English
Prior experience
- Principal Scientist, Johnson & Johnson, 2022-2024
- Senior Scientist, AstraZeneca, 2018-2022
- Postdoctoral Researcher/ Laboratory Head, Ludwig Maximilian University, Munich, 2016-2018
Education
- PhD Pharmaceutical Science/Oncology, Erasmus University, Rotterdam, the Netherlands, 2017
- MSc Molecular & Cellular Life Science, Utrecht University, Utrecht, the Netherlands, 2011
- BSc Biochemistry, HZ University of Applied Sciences, Vlissingen, the Netherlands, 2007